跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTIN-METFORMIN SANDOZ FILM COATED TABLET 50MG/500MG - HSA Drug Approval Details
Approvals
/
HSA
/
SITAGLIPTIN-METFORMIN SANDOZ FILM COATED TABLET 50MG/500MG
Approved
THERAPEUTIC
SITAGLIPTIN-METFORMIN SANDOZ FILM COATED TABLET 50MG/500MG
Sandoz Private Limited
🇸🇬 Health Sciences Authority
Approval Date
Oct 24, 2024
Approval ID
72a721ea4ca50193
Company
Sandoz Private Limited
Type
Therapeutic
Approval Details
Approval Id
72a721ea4ca50193
Drug Name
SITAGLIPTIN-METFORMIN SANDOZ FILM COATED TABLET 50MG/500MG
Product Name
SITAGLIPTIN-METFORMIN SANDOZ FILM COATED TABLET 50MG/500MG
Approval Number
SIN17121P
Approval Date
2024-10-24
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
A10BD07
Pharma Manufacturer Name
NOVARTIS (SINGAPORE) PTE LTD
Company Detail Path
/organization/novartis-singapore-pte-ltd
Active Ingredients
Metformin hydrochloride
500mg
Sitagliptin phosphate Monohydrate eqv Sitagliptin
50mg
Metformin hydrochloride
500mg
Sitagliptin phosphate Monohydrate eqv Sitagliptin
50mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 24, 2024
Approval ID
72a721ea4ca50193
Type
Therapeutic
Back to HSA Approvals
